| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Tenofovir Disoproxil Related Compound B (10 mg) ((E)-9-(Prop-1-enyl)-9H-purin-6-amine)
|
4121-40-8 |
((E)-9 - (丙-1 - 烯基)-9H-嘌呤-6 - 胺)
|
替诺福韦杂质2(9-丙烯基腺嘌呤);((E)-9-(丙-1-烯基)-9H-嘌呤-6-胺);替诺福韦杂质35;富马酸替诺福韦二吡呋酯杂质B;(E)-9-(1-烯-丙基)-9H-嘌呤-6-氨基;替诺福韦地索罗非尔富马酸酯IP杂质K;TENOFOVIR DISOPROXIL-8;替诺福韦酯杂质B
|
C8H9N5 |
175.19056 | |
|
(1S,2S)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
|
2964-48-9 |
(1S,2S)-2-氨基-1-(4-硝基苯基)丙烷-1,3-二醇
|
(1S,2S)-2-胺-1-(4-硝基苯)丙烷-1,3-二醇;(1S,2S)-2-氨基-1-(4-硝基苯)丙烷-1,3-二醇;精制左旋氨基物;2-氨基-1-(4-硝基苯基)丙烷-1,2S)-2-氨基-1-(4-硝基苯基)丙烷-1,3-二醇;右旋氨基物(右旋氨基二醇);1S,2S,米那普仑;(1S,2S)-(+)-2-氨基-1-(4-硝基苯基)-1,3-丙二醇
|
C9H13N2O4+ |
213.21052 | 221-001-4 |
|
2-[(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)] acetonitrile
|
93413-76-4 |
(1-羟环己基)(4-甲氧基苯基)乙腈
|
文拉法辛杂质3(文拉法辛羟基丁腈杂质);1-羟基环己基-4-甲氧基苯乙腈;文拉法辛氰杂质;1-羟基环己基-4-甲氧基乙腈;1-羟环己基)(4-甲氧基苯基)乙腈;文拉法辛含氰基杂质
|
C15H19NO2 |
245.32 | 618-945-8 |
|
Epoxy Exemestane (6-Beta Isomer)
|
152764-31-3 |
(2R,8R,9S,1R,13S,14S)-1,13-二甲基-7,8,9,11,12,13,15,16-八氢螺[环戊二烯并[A]菲并-6,2-噁丙环]-3,17(1H,14H)-二酮
|
(2R,8R,9S,10R,13S,14S)-10,13-二甲基-7,8,9,11,12,13,15,16-八氢螺[环戊二烯并[A]菲并-6,2-噁丙环]-3,17(10H,14H)-二酮;(2R,8R,9S,10R,13S,14S)-10,13-二甲基-7,8,9,11,12,13,15,16-八氢螺[环戊二烯并[A]菲并-6,2-噁丙环]-3,17(10H,14H)-二酮;依西美坦杂质G
|
C20H24O3 |
312.40276 | |
|
Diketo aldehyde impurity of dihydroartemisinin
|
1093625-96-7 |
(2S,3R,6R,S)-2 - (3 - 氧代丁基)-3 - 甲基-6 - [(R) - 2 - 丙醛]环己酮
|
(2S,3R,6R,S)-2-(3-氧代丁基)-3-甲基-6-[(R)-2-丙醛]环己酮
|
C14H22O3 |
238.32268 | |
|
Rasagiline Tartrate
|
136236-52-7 |
(2S,3S)-2,3-dihydroxybutanedioic acid,(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-a
|
|
C12H13N.1/2C4H6O6 |
492.5688 | |
|
Epoxy Exemestane (6-Alfa Isomer)
|
152764-24-4 |
(2S,8R,9S,1R,13S,14S)-1,13-二甲基-7,8,9,11,12,13,15,16-八氢螺[环戊二烯并[A]菲并-6,2-噁丙环]-3,17(1H,14H)-二酮
|
依西美坦杂质E;(2S,8R,9S,10R,13S,14S)-10,13-二甲基-7,8,9,11,12,13,15,16-八氢螺[环戊二烯并[A]菲并-6,2-噁丙环]-3,17(10H,14H)-二酮
|
C20H24O3 |
312.40276 | |
|
(2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
|
42399-49-5 |
(2S-cis)-(+)-2,3-二氢-3-羟基-2-(4-甲氧苯基)-1,5-苯并硫氮杂卓-4(5H)-酮
|
(2S-顺)-(+)-2,3-二氢-3-羟基-2-(4-甲氧基苯基)-1,5-苯噻氮卓-4(5H)-酮;(2S-CIS)-(+)-2,3-二氢-3-羟基-2-(4-甲氧苯基)-1,5-苯并硫氮杂卓-4(5;(2S)-顺-羟基内酰胺;(2S,3S)-2-(4-甲氧基苯基)-3-羟基-2,3-二氢-1,5-苯并硫氮杂卓-4(5H)-酮;(2S,3S)-(+)-2,5-苯并硫氮杂卓-4(5H)-酮;(2S)-顺-羟基内酰胺(盐酸地尔硫卓);地尔硫卓EP杂质E;2,3-二氢-6-(2-羟乙基)-5-甲基-7H-噻唑[3,2-A]并嘧啶-7-酮
|
C16H15NO3S |
301.36 | 255-799-0 |
|
4-0x0-4-[3-(trifluoromethy/l)-5,6-dinydro[1,2,4] triaz0lo[4,3-alpyrazin-7(8H)-y]-1-(2,4,5-trifluorophenyl) butan-2-one
|
764667-65-4 |
(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7-(8H)-基]-1-(2,4,5-三氟苯基)丁-2-酮
|
SITAGLIPTIN-11;西他列汀酮酰胺杂质;(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-A]吡嗪-7-(8H)-基]-1-(2,4,5-三氟苯基)丁-2-酮 764667-65-4;西他利汀杂质 B;西他列汀酮酰受杂质;4-氧代-4-[3-(三氟甲基)-5,5-三氟苯基)-2-丁酮;(2Z)-4-氧代-4-[3-(三氟甲基)-5,5-三氟苯基)丁-2-酮;4-氧-4-[3-(三氟甲基)-5,6-二氢[1,4]三唑[4,3-A]吡嗪-7(8H)-基]-1-(2,5-三氟甲基)丁基-2-酮
|
C16H12F6N4O2 |
406.28 | 619-997-4 |
|
(2Z)-4-0X0-4-13-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-alpyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl) but-2-en-2-amine.
|
767340-03-4 |
(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7(8H)-基]-1-(2,4,5-三氟苯基)丁-2-烯-2-胺
|
西他列汀杂质9;西格列汀杂质14;(2Z)-2-氨基-4-氧-4-[3-(三氟甲基)-5,6-二氢[1,2,4]三唑[4,3-Α]吡嗪-7(8H)-基]-1-(2,4,5-三氟苯基)丁基-2-烯(2-4);(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,4]三唑并[4,3-A]吡嗪-7(8H)-基]-1-(2,5-三氟苯基)-2-丁烯胺;SITAGLIPTIN-12;西格列汀烯胺杂质;7(8H)-基]-1-(245-三氟苯基)丁-2-烯-2-胺;西他列汀中间体3
|
C16H13F6N5O |
405.3 | 616-378-0 |
|
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate
|
291756-76-8 |
(2-氯-3-二甲氨基-亚-2-丙烯基)-二甲基-铵六氟磷酸盐
|
(Z)-N-(2-氯-3-(二甲基氨基)烯丙基亚甲基)-N-甲基甲胺六氟磷酸盐(V);N-[2-氯-3-(二甲氨基)烯丙基]-N-甲基甲铵六氟磷酸盐;(Z)-N-[2-氯-3-(二甲氨基)烯丙基烯]-N-甲基甲胺六氟磷酸盐;(2-氯-3-二甲氨基-亚-2-丙烯基)-二甲基-铵六氟磷酸盐;2-氯-1,3-双(二甲基氨基)六氟磷酸盐TRIMETHINIUM;(依托考昔中间体1);(Z)-N-[2-氯-3-(二甲氨基)亚烯丙基]-N-甲基甲铵六氟磷酸盐;(Z)-N-[2-氯-3-(二甲氨基)烯丙基] –N-甲基甲铵六氟磷酸盐
|
C7H14N2Cl+.F6P- |
306.61666 | |
|
(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropy]-4-[4-(phenylmethoxy) pheny]-2-azetidinone/E7
|
163222-32-0 |
(3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-羟基丙基]-4-[4-(苯甲氧基)苯基]-2-氮杂环丁酮
|
依泽替米贝苄醚杂质;(3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-羟丙基]-4-(4-苄氧苯基)-2-氮杂环丁酮;4'-O-苄氧依折麦布;EZ-ETL;依折麦布中间体6;依折麦布中级杂质;4'-O-苄基依泽替米贝;(3R,4S)-1-(4-氟苯基)-3-[(3S)-3-(4-氟苯基)-3-羟基丙基]-4-[4-(苯甲氧基)苯基]-2-氮杂环丁酮
|
C31H27NO3F2 |
499.54778 | 605-319-4 |
|
Androsta-1,4-diene-17-carboxylic acid,6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-,(6a,11B,16a,17)-
|
65429-42-7 |
(6a,11b,16a,17a)-6,9-二氟-11-羟基-16-甲基-3-氧代-17-(丙酰氧基)雄甾-1,4-二烯-17-羧酸
|
氟替卡松17Β-羧酸丙酸;氟替卡松EP杂质A;BNKY011-FP02;17Β羧酸丙酸氟替卡;6Α,9Α-二氟-11Β-羟基-16Α-甲基-3-氧代-17Α-(丙酰氧基)雄甾-1,4-二烯-17 Β-羧酸;(6A,11B,16A,17A)-6,9-二氟-11-羟基-16-甲基-3-氧代-17-(丙酰氧基)雄甾-1,4-二烯-17-羧酸;丙酸氟替卡松杂质A2;氟替卡松丙酸酯杂质1
|
C24H30O6F2 |
452.4882 | |
|
(R)-(+)-(3,4-Dimethoxy)benzyl-1-phenylethylamine
|
134430-93-6 |
(R)-(+)-(3,4-二甲氧基)苯-1-苯基乙胺
|
(R)-(+)-(3,4-二甲氧基)苯-1-苯基乙胺
|
C17H21NO2 |
271.35 | 200-589-5 |
|
(R)-Rabeprazole sodium
|
171440-18-9 |
(R)-雷贝拉唑钠盐
|
R-右雷贝拉唑钠盐;右旋雷贝啦唑钠(R-雷贝啦唑钠);(R)-雷贝拉唑钠盐;右旋雷贝拉唑;右雷贝拉唑钠;(R)-雷贝拉唑钠;右旋雷贝拉唑钠一水合物;雷贝拉唑杂质 15
|
C18H22N3NaO3S |
383.44035 | 1312995-182-4 |
|
Duloxetine metabolite Para-Naphthol Duloxetine
|
949095-98-1 |
(RS)-4-[3-甲氨基-1-(2-噻吩基)丙基]-1-萘酚
|
(RS)-4-[3-甲氨基-1-(2-噻吩基)丙基]-1-萘酚;4-[3-(甲基氨基)-1-(2-噻吩基)丙基]-1-萘酚;盐酸度洛西汀杂质C;盐酸度洛西汀EP杂质C;度洛西汀EP杂质C;度洛西汀杂质EP杂质C;DULOXETINE-3
|
C18H19NOS |
297.41456 | |
|
(S)-(-)-Anatabine
|
581-49-7 |
(S)-(-)-新烟草碱
|
(S)-(-)-新烟草碱;(S)-安那他品;(S)-安那他品;(S)-新烟草碱
|
C10H12N2 |
160.21568 | |
|
(S)-3-Amino-2-piperidone Hydrochloride
|
42538-31-8 |
(S)-3-氨基哌啶-2-酮盐酸盐
|
鸟氨酸-1,5-内酰胺盐酸盐;3-(S)-氨基-2-哌啶酮盐酸盐;ORNITHINE ASPARTATE-1;(3S)-3-氨基-2-哌啶酮盐酸盐;天冬氨酸杂质B
|
C5H11ClN2O |
150.61 | |
|
(S)-(+)-pipecolinoxylidide
|
27262-40-4 |
(S)-N-(2,6-二甲苯及)哌啶-2-甲酰胺
|
(S)-N-(2,6-二甲基苯基)-2-哌啶甲酰胺;N-去丙基罗哌卡因;(2S)-N-(2',6'-二甲苯基)-2-哌啶酰胺;(S)-N-(2',6'-二甲苯基)-2-哌啶甲酰胺(盐酸罗哌卡因中间体);(S)-N-(2,6-二甲基苯基)哌啶-2-甲酰胺;(S)-N-(2,6-二甲基苯基)哌啶-2-甲酰胺;罗哌卡因杂质2;(S)-N-(2',6'-二甲苯基)-2-哌啶甲酰胺
|
C14H20N2O |
232.32 | 608-069-4 |
|
Cefepime Impurity C
|
104301-63-5 |
(Z)-2-氨基-ALPHA-(甲氧基亚胺基)-N-(2-氧代乙基)-4-噻唑乙酰胺
|
(Z)-2-氨基-ALPHA-(甲氧基亚胺基)-N-(2-氧代乙基)-4-噻唑乙酰胺;头孢吡肟EP杂质C
|
C8H10N4O3S |
242.255 |
药智官方微信
药智官方微博
